Showing results (1381-1390 of 1,510) with videos related to

Sort By:
Pageof 151
Plos Medicine|May 17, 2006
Genome microevolution of chikungunya viruses causing the Indian Ocean outbreakIsabelle Schuffenecker, Isabelle Iteman, Alain Michault, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2013
Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paragangliomaJyotsna U Rao, Udo F H Engelke, Richard J T Rodenburg, et al.
Journal of Medical Genetics|July 8, 2020
A RIPOR2 in-frame deletion is a frequent and highly penetrant cause of adult-onset hearing lossSuzanne E de Bruijn, Jeroen J Smits, Chang Liu, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
SCALPEL: A pipeline for processing large-scale spatial transcriptomics dataMichael Kunst, Lindsey Ching, Jacob Quon, et al.
Oncotarget|January 19, 2017
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomasAttje S Hoekstra, Erik F Hensen, Ekaterina S Jordanova, et al.
Science (New York, N.Y.)|January 22, 2026
How malicious AI swarms can threaten democracyDaniel Thilo Schroeder, Meeyoung Cha, Andrea Baronchelli, et al.
JCO Oncology Practice|February 3, 2026
Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United StatesMichael S Leapman, Jessica B Long, Sarah Westvold, et al.
JAMA|August 31, 2024
Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical TrialBenjamin O'Brien, Niall G Campbell, Elizabeth Allen, et al.
Human Molecular Genetics|June 17, 1999
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 familiesP J Coucke, P Van Hauwe, P M Kelley, et al.
Oligonucleotides|July 20, 2007
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studiesPeter Hau, Piotr Jachimczak, Reimar Schlingensiepen, et al.
Pageof 151